[Modern therapy in blepharospasm].
OBJECTIVE
Pharmaceutical presentation of botulin A toxin (BAT) and its therapeutical use in ophthalmology in essential blepharospasm, as well. This work analyses the results and the disadvantages of the cure.


METHODS
During the last 3 years 21 patients suffering of essential blepharospasm have been cured. The cure with botulin A toxin administrated in efficient doses is followed by a 3-4 months period of pause.


RESULTS
At all the patients cured with Dysport, the symptoms have improved or weakened. The cure should be done at least twice a year (from 6 to 6 months) due to the "sprouting" axonal phenomenon.


CONCLUSIONS
The treatment of essential blepharospasm with botulin A toxin is a reliable and efficient method, with results relatively quickly installed. In treating this disease, it should be chosen from the very beginning.
Bereş
Aurora
A
Spitalul de Urgenţŭ Fogolyan Kristof, SF-Gheorghe.
D000368:Aged; D001764:Blepharospasm / Q000188:drug therapy*; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000008:administration & dosage* / Q000009:adverse effects; D012189:Retrospective Studies; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A